Varenzin - CA 1 (Molidustat) Oral Suspension 25mg/mL (27mL)

Varenzin™-CA1 (molidustat oral suspension) is the FIRST and ONLY FDA conditionally approved option for the treatment of non-regenerative anemia in cats with chronic kidney disease (CKD), setting the new standard of care for cats suffering from the debilitating effects of this often fatal disease.

Possible Side Effects 

Vomiting was the most frequently reported adverse event in preliminary studies. Increases in systolic blood pressure and mild transient increases in serum potassium were also observed.

Recommended Dosage

Use as directed by your veterinarian.